Country: Kanada
Bahasa: Inggeris
Sumber: Health Canada
NITRIC OXIDE
AIRGAS THERAPEUTICS LLC
R07AX01
NITRIC OXIDE
800PPM
GAS
NITRIC OXIDE 800PPM
INHALATION
362L/2138L
Prescription
NITRATES AND NITRITES
Active ingredient group (AIG) number: 0151361002; AHFS:
APPROVED
2016-12-01
PRODUCT MONOGRAPH PR KINOX™ nitric oxide for inhalation 100 ppm 800 ppm Manufactured by: Airgas Therapeutics LLC 6141 Easton Road Plumsteadville, Pennsylvania 18949-0310 USA Importer: VitalAire Canada Inc. 8 Bram Court Brampton, Ontario L6W 3R6 Control Number: 260152 KINOX is a trademark of Air Liquide Sante (International), Société Anonyme. Date of Preparation: January 25, 2016 Date of Revision: February 15, 2022 Page 2 of 26 PRODUCT MONOGRAPH PR KINOX™ NITRIC OXIDE FOR INHALATION 100 ppm 800 ppm ACTIONS AND CLINICAL PHARMACOLOGY Nitric oxide is a compound produced by many cells of the body. It relaxes vascular smooth muscle by binding to the heme moiety of cytosolic guanylate cyclase, activating guanylate cyclase and increasing intracellular levels of cyclic guanosine 3’,5’-monophosphate, which then leads to vasodilation. When inhaled, nitric oxide produces selective pulmonary vasodilation. Nitric oxide is very rapidly inactivated by binding to hemoglobin. Thus, delivered via inhalation, nitric oxide improves V/Q matching and is a selective pulmonary vasodilation agent. Inhaled nitric oxide appears to increase the partial pressure of arterial oxygen (PaO 2 ) by dilating pulmonary vessels in better ventilated areas of the lung, redistributing pulmonary blood flow away from lung regions with low ventilation/perfusion (V/Q) ratios toward regions with normal ratios. Effects on Pulmonary Vascular Tone in PPHN: Persistent pulmonary hypertension of the newborn (PPHN) occurs as a primary developmental defect or as a condition secondary to other diseases such as meconium aspiration syndrome (MAS), pneumonia, sepsis, hyaline membrane disease, congenital diaphragmatic hernia (CDH), and pulmonary hypoplasia. In these states, pulmonary vascular resistance (PVR) is high, which results in hypoxemia secondary to right-to-left shunting of blood through the patent ductus arteriosus and foramen ovale. Inhalation of nitric oxide reduces the oxygenation index (OI= mean airway pressure in cm H 2 O x fraction of inspired ox Baca dokumen lengkap